| 5.92 -0.06 (-1%) | 10-24 14:58 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.91 | 1-year : | 9.02 |
| Resists | First : | 6.77 | Second : | 7.72 |
| Pivot price | 6.19  |
|||
| Supports | First : | 5.25 | Second : | 4.36 |
| MAs | MA(5) : | 5.88 |
MA(20) : | 6.09 |
| MA(100) : | 7.42 |
MA(250) : | 9.17 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 18.5 |
D(3) : | 20.7 |
| RSI | RSI(14): 47.2 |
|||
| 52-week | High : | 19 | Low : | 5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RBOT ] has closed above bottom band by 33.1%. Bollinger Bands are 37.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.29 - 6.32 | 6.32 - 6.36 |
| Low: | 5.56 - 5.61 | 5.61 - 5.65 |
| Close: | 5.92 - 5.98 | 5.98 - 6.04 |
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Wed, 08 Oct 2025
Vicarious Surgical Announces $5.9 Million Direct Offering - TipRanks
Wed, 08 Oct 2025
$5.9M Proceeds: Vicarious Surgical Prices Registered Direct Offering; 1.15M Shares to Close Oct 9 - Stock Titan
Thu, 25 Sep 2025
Vicarious Surgical Announces Appointment of Joseph Doherty as Chairman of The Board - The Globe and Mail
Thu, 25 Sep 2025
Vicarious Surgical appoints Joseph Doherty as board chairman - Investing.com
Thu, 25 Sep 2025
Vicarious Surgical Appoints Joseph Doherty as Chairman of The Board - citybiz
Wed, 27 Aug 2025
Next-Gen Robotic Surgery Pioneer Vicarious Surgical to Showcase Technology at Global Investment Conference - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 6 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 20.3 (%) |
| Held by Institutions | 30.3 (%) |
| Shares Short | 156 (K) |
| Shares Short P.Month | 130 (K) |
| EPS | -10.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.88 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -57.8 % |
| Return on Equity (ttm) | -125.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -10.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -50 (M) |
| Levered Free Cash Flow | -28 (M) |
| PE Ratio | -0.59 |
| PEG Ratio | 0 |
| Price to Book value | 1.52 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|